ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS

ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS

Non-steroidal anti-inflammatory drugs (NSAIDs) are liders in selling both in the Russian Federation and worldwide. The combination of analgesic, anti-inflammatory and antipyretic effects make the drugs of this group very popular in patients with various diseases. The realization of NSAIDs in phar...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. Yu. Velts, T. M. Bukatina, E. O. Zhuravleva, G. V. Kutekhova, M. A. Darmostukova, Yu. V. Olefir, B. K. Romanov, S. V. Glagolev, V. A. Polivanov
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2018-09-01
Series:	Безопасность и риск фармакотерапии
Subjects:	non-steroidal anti-inflammatory drugs off-label over-the-counter drugs drug safety pharmacovigilance
Online Access:	https://www.risksafety.ru/jour/article/view/113
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

EVALUATION OF SAFETY OF DRUG THERAPY IN CLINICAL PRACTICE
by: M. N. Kostyleva, et al.
Published: (2015-03-01)

International Drug Safety Monitoring
by: A. S. Kazakov, et al.
Published: (2019-09-01)

Expert Evaluation of Pharmacovigilance System Documents Included in the Registration Dossier
by: I. I. Snegireva, et al.
Published: (2020-12-01)

Season of Colds and Flu is in Full Swing: Treating Cough
by: Svetlana V. Ilyina
Published: (2018-02-01)

Off-Label Drug Use in Pediatric Practice: Unsolved Problems
by: A. R. Titova, et al.
Published: (2015-10-01)

Assessment of self-treatment in terms of inappropriate prescribing registry
by: S. Yu. Martsevich, et al.
Published: (2025-04-01)

Off-label antibiotic use in a specialized children care hospital in Punjab, Pakistan: Findings and implications
by: Muhammad Hafeez, et al.
Published: (2020-05-01)

The Adverse Drug Reactions Registered During the Postmarketing Period
by: E. V. Shubnikova, et al.
Published: (2019-03-01)

SIGNAL AS A TOOL OF THE PHARMACOVIGILANCE
by: E. O. Zhuravleva, et al.
Published: (2018-06-01)

Safety of the Off-Label Use of Antitumor Drugs in Real Clinical Practice: Experience of Oncologists of the Russian Federation
by: E. V. Каrabina, et al.
Published: (2024-12-01)

Medication use in the neonatal intensive care unit in a tertiary hospital in China from 2020 to 2023
by: Yi Wang, et al.
Published: (2025-05-01)

Guidelines for the planning and implementation of pharmacovigilance systems audit
by: S. V. Glagolev, et al.
Published: (2018-02-01)

Current Information on the Safety of Medicinal Products: Decisions of Foreign Regulatory Authorities
by: E. V. Shubnikova
Published: (2024-04-01)

Submission of Documents on the Pharmacovigilance System as Part of the Registration Dossier within the Framework of the EAEU Procedures: Analysis of Requirements and Typical Errors
by: N. Yu. Velts, et al.
Published: (2024-10-01)

Comparative Analysis of International Databases of Adverse Drug Reactions
by: A. S. Kazakov, et al.
Published: (2020-09-01)

Drug Safety Monitoring—International Information
by: E. V. Shubnikova, et al.
Published: (2020-12-01)

ON THE SAFETY OF ANTIBACTERIAL DRUGS USED IN PEDIATRICS
by: A. R. Titova, et al.
Published: (2018-02-01)

Legal Responsibility of Doctor Regarding off-label Drug Applications
by: Erdal Yüzbaşıoğlu
Published: (2012-03-01)

Typical pharmacovigilance system master file (PSMF)
by: B. K. Romanov, et al.
Published: (2018-02-01)

Guidelines for the Preparation of a Document Containing the Drug Safety Monitoring Results
by: Yu. V. Olefir, et al.
Published: (2018-02-01)

Review of the monograph by Kolbin A. S., Zyryanov S. K., Belousov D. Yu. "Pharmacovigilance" 2025
by: V. I. Petrov
Published: (2025-01-01)

Therapy with non-steroidal anti-inflammatory drugs and the quality of life of patients with rheumatic diseases
by: E. Yu. Polishchuk, et al.
Published: (2022-02-01)

Prescribing Drugs not in Accordance with the Official Instructions for Medical Use (Off-label), Clinical Guidelines, Standards of Medical Care and Legal Regulation in the Russian Federation. Part 2
by: A. R. Navasardyan, et al.
Published: (2021-05-01)

Analysis of the Causes for Renal Dysfunction during Antibiotic Therapy in a Patient with Lyme Disease
by: N. Yu. Velts, et al.
Published: (2022-10-01)

Peculiarities of non-steroidal anti-inflammatory drugs in the treatment of complicated caries in patients with concomitant somatic pathology
by: L. Yu. Orekhova, et al.
Published: (2021-04-01)

Topical Issues of Drug Safety, Possibilities of Improving of Pharmacovigilance
by: M. V. Zhuravleva, et al.
Published: (2019-09-01)

Investigation of the analgesic efficacy of local therapy with non-steroidal anti-inflammatory drugs in patients with knee osteoarthritis
by: E. A. Strebkova, et al.
Published: (2024-10-01)

Renal safety of Long-Term Non-steroidal Anti-inflammatory drugs use in patients with ankylosing spondylitis
by: Young-Eun Kim, et al.
Published: (2025-07-01)

Problematic aspects of participation of pharmacists in the system of pharmacovigilance in Russia
by: E. N. Tkhoseva, et al.
Published: (2022-06-01)

Monitoring of drug safety
by: B. K. Romanov, et al.
Published: (2022-06-01)

Managing risks and harms associated with the use of anabolic steroids: a qualitative study
by: J. M. X. Amaral, et al.
Published: (2025-07-01)

Unanswered Questions in Pediatric Clinical Trials: Literature Review
by: Leyla S. Namazova-Baranova, et al.
Published: (2022-03-01)

Off-Label Drug Use in Oncology
by: E. V. Karabina, et al.
Published: (2022-07-01)

Levofloxacin: Analysis of Information on Adverse Reactions from Russian Spontaneous Report Database
by: S. K. Zyryanov, et al.
Published: (2020-05-01)

Non-steroidal anti-inflammatory drugs for osteoarthritis and non-specific back pain: basic provisions for effective and safe use (Interdisciplinary consensus)
by: A. M. Lila, et al.
Published: (2024-12-01)

Drug Safety Monitoring Information
by: E. V. Shubnikova, et al.
Published: (2021-07-01)

Safety of Pharmacotherapy in COVID-19 Patients: A Literature Review
by: A. V. Kryukov, et al.
Published: (2022-12-01)

Awareness of doctors and epilepsy patients about preferential drug provision
by: A. S. Romanov, et al.
Published: (2023-07-01)

Nanoscale Therapeutic System: Safety Assessment Features
by: E. M. Bovina, et al.
Published: (2019-09-01)

A narrative review of veterinary pharmacovigilance situations and prospects in East African countries
by: Yesuneh Tefera Mekasha, et al.
Published: (2024-11-01)